down arrow

Teleflex, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US8793691069
USD
118.86
-0.26 (-0.22%)

Dec 04

NYS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

117.42119.53

52 Week

102.58188.87
Valuation
Technical
Day's Volume

CASH

383.86 k

Shareholding (Mar 2025)

FII

20.79%

Held by 274 FIIs

DII

0

Held by 89 DIIs

Promoter

0.23%

How big is Teleflex, Inc.?

22-Jun-2025

As of Jun 18, Teleflex, Inc. has a market capitalization of $5.32 billion, with net sales of $3.01 billion and a net profit of $149.53 million for the latest four quarters. The balance sheet shows shareholder's funds of $4.28 billion and total assets of $7.10 billion.

As of Jun 18, Teleflex, Inc. has a market capitalization of 5,319.41 million, categorizing it as a Mid Cap company.<BR><BR>As of Jun 18, the company reported net sales of 3,010.15 million and a net profit of 149.53 million for the latest four quarters ending in March 2025, December 2024, September 2024, and June 2024.<BR><BR>As of December 2024, the balance sheet shows shareholder's funds of 4,278.14 million and total assets of 7,097.91 million.

Read More

What does Teleflex, Inc. do?

22-Jun-2025

Teleflex, Inc. is a mid-cap provider of medical technology products in the Pharmaceuticals & Biotechnology industry, with recent net sales of $701 million and a market cap of approximately $5.32 billion. Key financial metrics include a P/E ratio of 13.00 and a dividend yield of 1.20%.

Overview:<BR>Teleflex, Inc. is a provider of medical technology products in the Pharmaceuticals & Biotechnology industry, operating in the mid-cap market segment.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 701 Million (Quarterly Results - Mar 2025)<BR>Most recent Net Profit: 95 Million (Quarterly Results - Mar 2025)<BR>Market-cap: USD 5,319.41 Million (Mid Cap)<BR><BR>Key Metrics:<BR>P/E: 13.00<BR>Dividend Yield: 1.20%<BR>Debt Equity: 0.40<BR>Return on Equity: 10.18%<BR>Price to Book: 1.30<BR><BR>Contact Details:<BR>Address: 550 E Swedesford Rd Ste 400, WAYNE PA: 19087-1601<BR>Tel: ['1 610 2256800', '1 610 9482836']<BR>Fax: 1 610 9485101<BR>Website: https://www.teleflex.com/

Read More

Who are in the management team of Teleflex, Inc.?

22-Jun-2025

As of March 2022, the management team of Teleflex, Inc. includes Liam Kelly as Chairman, President, and CEO, with George Babich as Lead Independent Director and several Independent Directors: Candace Duncan, Gretchen Haggerty, John Heinmiller, and Stephen Klasko.

As of March 2022, the management team of Teleflex, Inc. includes Mr. Liam Kelly, who serves as the Chairman of the Board, President, and Chief Executive Officer. The board also features Mr. George Babich as the Lead Independent Director, along with several Independent Directors: Ms. Candace Duncan, Ms. Gretchen Haggerty, Mr. John Heinmiller, and Dr. Stephen Klasko.

Read More

Is Teleflex, Inc. overvalued or undervalued?

21-Oct-2025

As of October 17, 2025, Teleflex, Inc. is considered very expensive and overvalued, with a P/E ratio of 13 and significant underperformance compared to the S&P 500, showing a year-to-date return of -28.01% and a 5-year return of -64.93%.

As of 17 October 2025, the valuation grade for Teleflex, Inc. has moved from attractive to very expensive, indicating a shift towards overvaluation. The company appears overvalued based on its current metrics, with a P/E ratio of 13, an EV to EBITDA of 8.74, and a PEG ratio of 0.39. In comparison, peers such as Hologic, Inc. have a P/E of 21.83, while The Cooper Cos., Inc. shows a significantly higher P/E of 34.28, further emphasizing Teleflex's relative overvaluation.<BR><BR>Recent performance shows that Teleflex has underperformed compared to the S&P 500, with a year-to-date return of -28.01% against the index's 13.30%. This trend continues over longer periods, with a 5-year return of -64.93% compared to the S&P 500's 91.29%, reinforcing the notion that Teleflex is currently overvalued in the market.

Read More

Is Teleflex, Inc. technically bullish or bearish?

05-Nov-2025

As of October 31, 2025, Teleflex, Inc. shows a mildly bearish trend with mixed technical indicators, underperforming the S&P 500 significantly, having a year-to-date return of -30.10% compared to the index's 16.30%.

As of 31 October 2025, the technical trend for Teleflex, Inc. has changed from sideways to mildly bearish. The weekly MACD indicates a mildly bullish stance, while the monthly MACD is bearish. The RSI shows no signal on the weekly chart but is bullish on the monthly. Moving averages are bearish on the daily timeframe. The KST is bullish weekly but bearish monthly, and Dow Theory suggests a mildly bearish outlook on the weekly chart with no trend monthly. <BR><BR>In terms of performance, Teleflex has underperformed significantly compared to the S&P 500 across multiple periods, with a year-to-date return of -30.10% versus the S&P 500's 16.30%, and a one-year return of -41.10% compared to 19.89% for the index. Overall, the current technical stance is mildly bearish, driven by the bearish moving averages and mixed signals from MACD and KST.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Poor long term growth as Net Sales has grown by an annual rate of 3.78% and Operating profit at 3.08% over the last 5 years

  • INTEREST(Q) At USD 24.95 MM has Grown at 17.73%
  • DIVIDEND PAYOUT RATIO(Y) Lowest at 12.3%
  • DEBT-EQUITY RATIO (HY) Highest at 40.7 %
2

Risky -

3

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 5,892 Million (Small Cap)

stock-summary
P/E

13.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

1.08%

stock-summary
Debt Equity

0.38

stock-summary
Return on Equity

11.18%

stock-summary
Price to Book

1.39

Revenue and Profits:
Net Sales:
781 Million
(Quarterly Results - Jun 2025)
Net Profit:
123 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-7.92%
0%
-7.92%
6 Months
-3.17%
0%
-3.17%
1 Year
-36.55%
0%
-36.55%
2 Years
-48.18%
0%
-48.18%
3 Years
-51.0%
0%
-51.0%
4 Years
-61.06%
0%
-61.06%
5 Years
-69.28%
0%
-69.28%

Teleflex, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Teleflex Stock Hits Day Low of $102.58 Amid Price Pressure

Teleflex Stock Hits Day Low of $102.58 Amid Price Pressure

Teleflex, Inc. has faced notable volatility, with a significant stock decline today. Over the past year, the company has underperformed compared to the S&P 500. Despite a low debt-to-equity ratio and strong interest coverage, long-term growth appears limited, with modest increases in net sales and operating profit.

Read More
Teleflex, Inc. Stock Plummets to New 52-Week Low of $102.58

Teleflex, Inc. Stock Plummets to New 52-Week Low of $102.58

Teleflex, Inc. has reached a new 52-week low, reflecting a significant decline in its stock performance over the past year compared to the S&P 500. The company, with a market cap of approximately USD 5,892 million, faces challenges in long-term growth despite some positive financial metrics.

Read More

Is Teleflex, Inc. technically bullish or bearish?

As of 31 October 2025, the technical trend for Teleflex, Inc. has changed from sideways to mildly bearish. The weekly MACD indicates a mildly bullish stance, while the monthly MACD is bearish. The RSI shows no signal on the weekly chart but is bullish on the monthly. Moving averages are bearish on the daily timeframe. The KST is bullish weekly but bearish monthly, and Dow Theory suggests a mildly bearish outlook on the weekly chart with no trend monthly. In terms of performance, Teleflex has underperformed significantly compared to the S&P 500 across multiple periods, with a year-to-date return of -30.10% versus the S&P 500's 16.30%, and a one-year return of -41.10% compared to 19.89% for the index. Overall, the current technical stance is mildly bearish, driven by the bearish moving averages and mixed signals from MACD and KST....

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
3.78%
EBIT Growth (5y)
3.08%
EBIT to Interest (avg)
5.78
Debt to EBITDA (avg)
2.12
Net Debt to Equity (avg)
0.40
Sales to Capital Employed (avg)
0.49
Tax Ratio
28.88%
Dividend Payout Ratio
91.92%
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
9.41%
ROE (avg)
9.86%
Valuation key factors
Factor
Value
P/E Ratio
13
Industry P/E
Price to Book Value
1.36
EV to EBIT
13.16
EV to EBITDA
8.74
EV to Capital Employed
1.26
EV to Sales
2.39
PEG Ratio
0.39
Dividend Yield
1.15%
ROCE (Latest)
9.55%
ROE (Latest)
10.18%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
Bullish
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 129 Schemes (80.62%)

Foreign Institutions

Held by 274 Foreign Institutions (20.79%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 4.16% vs 0.86% in Jun 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 52.87% vs -28.01% in Jun 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "780.90",
          "val2": "749.70",
          "chgp": "4.16%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "244.40",
          "val2": "194.30",
          "chgp": "25.78%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "25.00",
          "val2": "25.80",
          "chgp": "-3.10%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-24.60",
          "val2": "-9.30",
          "chgp": "-164.52%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "122.60",
          "val2": "80.20",
          "chgp": "52.87%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "228.80%",
          "val2": "168.20%",
          "chgp": "6.06%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 2.45% vs 6.57% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -80.37% vs -1.46% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3,047.30",
          "val2": "2,974.50",
          "chgp": "2.45%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "838.60",
          "val2": "816.20",
          "chgp": "2.74%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "102.60",
          "val2": "116.10",
          "chgp": "-11.63%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-280.30",
          "val2": "-27.00",
          "chgp": "-938.15%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "70.20",
          "val2": "357.60",
          "chgp": "-80.37%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "185.10%",
          "val2": "193.00%",
          "chgp": "-0.79%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoYstock-summary
Jun'25
Jun'24
Change(%)
Net Sales
780.90
749.70
4.16%
Operating Profit (PBDIT) excl Other Income
244.40
194.30
25.78%
Interest
25.00
25.80
-3.10%
Exceptional Items
-24.60
-9.30
-164.52%
Consolidate Net Profit
122.60
80.20
52.87%
Operating Profit Margin (Excl OI)
228.80%
168.20%
6.06%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Jun 2025 is 4.16% vs 0.86% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is 52.87% vs -28.01% in Jun 2024

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
3,047.30
2,974.50
2.45%
Operating Profit (PBDIT) excl Other Income
838.60
816.20
2.74%
Interest
102.60
116.10
-11.63%
Exceptional Items
-280.30
-27.00
-938.15%
Consolidate Net Profit
70.20
357.60
-80.37%
Operating Profit Margin (Excl OI)
185.10%
193.00%
-0.79%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 2.45% vs 6.57% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -80.37% vs -1.46% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Teleflex, Inc. stock-summary
stock-summary
Teleflex, Inc.
Pharmaceuticals & Biotechnology
Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM). The Company's products include oxygen therapy products, aerosol therapy products, spirometry products, and ventilation management products, which are offered under Hudson RCI brand. As of December 31, 2016, it manufactured its products at approximately 30 manufacturing sites, with manufacturing operations located in the Czech Republic, Germany, Malaysia, Mexico and the United States. Its all others businesses include single-use respiratory, urology and cardiac care products, as well as capital equipment.
Company Coordinates stock-summary
Company Details
550 E Swedesford Rd Ste 400 , WAYNE PA : 19087-1601
stock-summary
Tel: 1 610 22568001 610 9482836
stock-summary
https://www.teleflex.com/
stock-summary
Registrar Details
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."